Literature DB >> 25827874

Isolation of specific genomic regions and identification of associated molecules by engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP) using CRISPR.

Toshitsugu Fujita1, Hodaka Fujii.   

Abstract

Isolation of specific genomic regions retaining molecular interactions is necessary for their biochemical analysis. Here, we describe engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP) using the CRISPR system, for purification of specific genomic regions retaining molecular interactions. In this form of enChIP, specific genomic regions are immunoprecipitated with antibody against a tag(s), which is fused to a catalytically inactive form of Cas9 (dCas9), which is co-expressed with a guide RNA (gRNA) and recognizes endogenous DNA sequence in the genomic regions of interest. enChIP combined with mass spectrometry (enChIP-MS), next-generation sequencing (enChIP-Seq), and RNA-Seq (enChIP-RNA-Seq) can identify proteins, other genomic regions, and RNA, respectively, that interact with the target genomic region.

Mesh:

Substances:

Year:  2015        PMID: 25827874     DOI: 10.1007/978-1-4939-2474-5_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

1.  Adaptation of Hybridization Capture of Chromatin-associated Proteins for Proteomics to Mammalian Cells.

Authors:  Hector Guillen-Ahlers; Prahlad K Rao; Danu S Perumalla; Maria J Montoya; Avinash Y L Jadhav; Michael R Shortreed; Lloyd M Smith; Michael Olivier
Journal:  J Vis Exp       Date:  2018-06-01       Impact factor: 1.355

2.  Overview of CRISPR-Cas9 Biology.

Authors:  Hannah K Ratner; Timothy R Sampson; David S Weiss
Journal:  Cold Spring Harb Protoc       Date:  2016-12-01

3.  In vitro Engineered DNA-binding Molecule-mediated Chromatin Immunoprecipitation (in vitro enChIP) Using CRISPR Ribonucleoproteins in Combination with Next-generation Sequencing (in vitro enChIP-Seq) for the Identification of Chromosomal Interactions.

Authors:  Toshitsugu Fujita; Hodaka Fujii
Journal:  Bio Protoc       Date:  2017-11-20

Review 4.  CRISPR/Cas9-Based Engineering of the Epigenome.

Authors:  Julian Pulecio; Nipun Verma; Eva Mejía-Ramírez; Danwei Huangfu; Angel Raya
Journal:  Cell Stem Cell       Date:  2017-10-05       Impact factor: 24.633

Review 5.  Applications of Engineered DNA-Binding Molecules Such as TAL Proteins and the CRISPR/Cas System in Biology Research.

Authors:  Toshitsugu Fujita; Hodaka Fujii
Journal:  Int J Mol Sci       Date:  2015-09-24       Impact factor: 5.923

Review 6.  Isolation of Specific Genomic Regions and Identification of Their Associated Molecules by Engineered DNA-Binding Molecule-Mediated Chromatin Immunoprecipitation (enChIP) Using the CRISPR System and TAL Proteins.

Authors:  Hodaka Fujii; Toshitsugu Fujita
Journal:  Int J Mol Sci       Date:  2015-09-09       Impact factor: 5.923

7.  Allele-specific locus binding and genome editing by CRISPR at the p16INK4a locus.

Authors:  Toshitsugu Fujita; Miyuki Yuno; Hodaka Fujii
Journal:  Sci Rep       Date:  2016-07-28       Impact factor: 4.379

Review 8.  Biochemical Analysis of Genome Functions Using Locus-Specific Chromatin Immunoprecipitation Technologies.

Authors:  Toshitsugu Fujita; Hodaka Fujii
Journal:  Gene Regul Syst Bio       Date:  2016-01-18

9.  TALEN/CRISPR-mediated engineering of a promoterless anti-viral RNAi hairpin into an endogenous miRNA locus.

Authors:  Elena Senís; Stefan Mockenhaupt; Daniel Rupp; Tobias Bauer; Nagarajan Paramasivam; Bettina Knapp; Jan Gronych; Stefanie Grosse; Marc P Windisch; Florian Schmidt; Fabian J Theis; Roland Eils; Peter Lichter; Matthias Schlesner; Ralf Bartenschlager; Dirk Grimm
Journal:  Nucleic Acids Res       Date:  2016-09-09       Impact factor: 16.971

Review 10.  CRISPR Genome Engineering for Human Pluripotent Stem Cell Research.

Authors:  Somali Chaterji; Eun Hyun Ahn; Deok-Ho Kim
Journal:  Theranostics       Date:  2017-10-07       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.